BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34436017)

  • 21. Evidence for frequent concurrent DCUN1D1, FGFR1, BCL9 gene copy number amplification in squamous cell lung cancer.
    Chatziandreou I; Psaraki A; Paschidis K; Lazaris AC; Saetta AA
    Pathol Res Pract; 2021 May; 221():153412. PubMed ID: 33862557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PIK3CA as an oncogene in cervical cancer.
    Ma YY; Wei SJ; Lin YC; Lung JC; Chang TC; Whang-Peng J; Liu JM; Yang DM; Yang WK; Shen CY
    Oncogene; 2000 May; 19(23):2739-44. PubMed ID: 10851074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosome 20q11.21 Amplifications in Colorectal Cancer.
    Voutsadakis IA
    Cancer Genomics Proteomics; 2021; 18(3 Suppl):487-496. PubMed ID: 33994370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrative genomics analysis identifies candidate drivers at 3q26-29 amplicon in squamous cell carcinoma of the lung.
    Wang J; Qian J; Hoeksema MD; Zou Y; Espinosa AV; Rahman SM; Zhang B; Massion PP
    Clin Cancer Res; 2013 Oct; 19(20):5580-90. PubMed ID: 23908357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of novel candidate target genes, including EPHB3, MASP1 and SST at 3q26.2-q29 in squamous cell carcinoma of the lung.
    Kang JU; Koo SH; Kwon KC; Park JW; Kim JM
    BMC Cancer; 2009 Jul; 9():237. PubMed ID: 19607727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent copy number gains drive PKCι expression and PKCι-dependent oncogenic signaling in human cancers.
    Liu Y; Justilien V; Fields AP; Murray NR
    Adv Biol Regul; 2020 Dec; 78():100754. PubMed ID: 32992230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110alpha in squamous cell carcinoma of the oral tongue.
    Estilo CL; O-Charoenrat P; Ngai I; Patel SG; Reddy PG; Dao S; Shaha AR; Kraus DH; Boyle JO; Wong RJ; Pfister DG; Huryn JM; Zlotolow IM; Shah JP; Singh B
    Clin Cancer Res; 2003 Jun; 9(6):2300-6. PubMed ID: 12796399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex determining region Y-box 2 (SOX2) amplification is an independent indicator of disease recurrence in sinonasal cancer.
    Schröck A; Göke F; Wagner P; Bode M; Franzen A; Braun M; Huss S; Agaimy A; Ihrler S; Menon R; Kirsten R; Kristiansen G; Bootz F; Lengerke C; Perner S
    PLoS One; 2013; 8(3):e59201. PubMed ID: 23544055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene amplification at chromosome 1pter-p33 including the genes PAX7 and ENO1 in squamous cell lung carcinoma.
    Rácz A; Brass N; Höfer M; Sybrecht GW; Remberger K; Meese EU
    Int J Oncol; 2000 Jul; 17(1):67-73. PubMed ID: 10853020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PIK3CA gene mutations and amplifications in uterine cancers, identified by methods that avoid confounding by PIK3CA pseudogene sequences.
    Miyake T; Yoshino K; Enomoto T; Takata T; Ugaki H; Kim A; Fujiwara K; Miyatake T; Fujita M; Kimura T
    Cancer Lett; 2008 Mar; 261(1):120-6. PubMed ID: 18180098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined
    Montoro-Jiménez I; Granda-Díaz R; Menéndez ST; Prieto-Fernández L; Otero-Rosales M; Álvarez-González M; García-de-la-Fuente V; Rodríguez A; Rodrigo JP; Álvarez-Teijeiro S; García-Pedrero JM; Hermida-Prado F
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancer.
    Wilting SM; de Wilde J; Meijer CJ; Berkhof J; Yi Y; van Wieringen WN; Braakhuis BJ; Meijer GA; Ylstra B; Snijders PJ; Steenbergen RD
    Genes Chromosomes Cancer; 2008 Oct; 47(10):890-905. PubMed ID: 18618715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 8p11.23 Amplification in Breast Cancer: Molecular Characteristics, Prognosis and Targeted Therapy.
    Voutsadakis IA
    J Clin Med; 2020 Sep; 9(10):. PubMed ID: 32987805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathological and biological analysis of
    Razia S; Nakayama K; Nakamura K; Ishibashi T; Ishikawa M; Minamoto T; Iida K; Otsuki Y; Nakayama S; Ishikawa N; Kyo S
    Exp Ther Med; 2019 Sep; 18(3):2278-2284. PubMed ID: 31410178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SNO is a probable target for gene amplification at 3q26 in squamous-cell carcinomas of the esophagus.
    Imoto I; Pimkhaokham A; Fukuda Y; Yang ZQ; Shimada Y; Nomura N; Hirai H; Imamura M; Inazawa J
    Biochem Biophys Res Commun; 2001 Aug; 286(3):559-65. PubMed ID: 11511096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma.
    Rao PH; Arias-Pulido H; Lu XY; Harris CP; Vargas H; Zhang FF; Narayan G; Schneider A; Terry MB; Murty VV
    BMC Cancer; 2004 Feb; 4():5. PubMed ID: 15018632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequent overexpression of the genes FXR1, CLAPM1 and EIF4G located on amplicon 3q26-27 in squamous cell carcinoma of the lung.
    Comtesse N; Keller A; Diesinger I; Bauer C; Kayser K; Huwer H; Lenhof HP; Meese E
    Int J Cancer; 2007 Jun; 120(12):2538-44. PubMed ID: 17290396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TERT promoter hot spot mutations are frequent in Indian cervical and oral squamous cell carcinomas.
    Vinothkumar V; Arunkumar G; Revathidevi S; Arun K; Manikandan M; Rao AK; Rajkumar KS; Ajay C; Rajaraman R; Ramani R; Murugan AK; Munirajan AK
    Tumour Biol; 2016 Jun; 37(6):7907-13. PubMed ID: 26700669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigations for fine mapping of amplifications in chromosome 3q26.3-28 frequently occurring in squamous cell carcinomas of the head and neck.
    Riazimand SH; Welkoborsky HJ; Bernauer HS; Jacob R; Mann WJ
    Oncology; 2002; 63(4):385-92. PubMed ID: 12417794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Landscape of genomic alterations in cervical carcinomas.
    Ojesina AI; Lichtenstein L; Freeman SS; Pedamallu CS; Imaz-Rosshandler I; Pugh TJ; Cherniack AD; Ambrogio L; Cibulskis K; Bertelsen B; Romero-Cordoba S; Treviño V; Vazquez-Santillan K; Guadarrama AS; Wright AA; Rosenberg MW; Duke F; Kaplan B; Wang R; Nickerson E; Walline HM; Lawrence MS; Stewart C; Carter SL; McKenna A; Rodriguez-Sanchez IP; Espinosa-Castilla M; Woie K; Bjorge L; Wik E; Halle MK; Hoivik EA; Krakstad C; Gabiño NB; Gómez-Macías GS; Valdez-Chapa LD; Garza-Rodríguez ML; Maytorena G; Vazquez J; Rodea C; Cravioto A; Cortes ML; Greulich H; Crum CP; Neuberg DS; Hidalgo-Miranda A; Escareno CR; Akslen LA; Carey TE; Vintermyr OK; Gabriel SB; Barrera-Saldaña HA; Melendez-Zajgla J; Getz G; Salvesen HB; Meyerson M
    Nature; 2014 Feb; 506(7488):371-5. PubMed ID: 24390348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.